These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 657100)
1. Non-Hodgkin's lymphoma in children: an analysis of 122 cases from Argentina. Cebrian-Bonesana A; Schvartzman E; Roca-Garcia C; Pependieck C; Sackmann-Muriel S; Ojeda FG; Kvicala R; Pavlovsky S; Lein JM; Penchansky L Cancer; 1978 Jun; 41(6):2372-8. PubMed ID: 657100 [TBL] [Abstract][Full Text] [Related]
2. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220 [TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma in children. Brecher ML; Sinks LF; Thomas RR; Freeman AI Cancer; 1978 May; 41(5):1997-2001. PubMed ID: 348300 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two consecutive trials for treatment of childhood non-Hodgkin's lymphoma. Sackmann-Muriel F; Diez B; Schvartzman E; Braier JL; Schwartz L; Gallo G; Pavlovsky S Cancer; 1984 Dec; 54(12):2863-8. PubMed ID: 6388820 [TBL] [Abstract][Full Text] [Related]
5. [Malignant lymphoma]. Streuli RA Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304 [No Abstract] [Full Text] [Related]
6. [Non-Hodgkin's lymphoma in children: improved prognosis through aggressive multiple drug combination and irradiation (author's transl)]. Janka GE; Lau BM; Meister P; Lampert F; Haas RJ Klin Padiatr; 1979 Jan; 191(1):40-6. PubMed ID: 569731 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia. Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296 [TBL] [Abstract][Full Text] [Related]
8. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. Mauz-Körholz C; Hasenclever D; Dörffel W; Ruschke K; Pelz T; Voigt A; Stiefel M; Winkler M; Vilser C; Dieckmann K; Karlén J; Bergsträsser E; Fosså A; Mann G; Hummel M; Klapper W; Stein H; Vordermark D; Kluge R; Körholz D J Clin Oncol; 2010 Aug; 28(23):3680-6. PubMed ID: 20625128 [TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy. Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470 [TBL] [Abstract][Full Text] [Related]
10. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease. Tubiana M; Mathé G Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180 [No Abstract] [Full Text] [Related]
11. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5. Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of Hodgkin's disease in children. Kolygin BA Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072 [TBL] [Abstract][Full Text] [Related]
13. Results of combination chemotherapy of non-Hodgkin's lymphoma. Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932 [TBL] [Abstract][Full Text] [Related]
14. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809. Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664 [TBL] [Abstract][Full Text] [Related]
15. Successful chemotherapy of advanced non-Hodgkin's lymphoma after relapse following total body irradiation. Brereton HD; Fairey RN; Johnson RE Int J Radiat Oncol Biol Phys; 1977; 2(3-4):249-55. PubMed ID: 577206 [No Abstract] [Full Text] [Related]
16. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma. Durant JR; Gams RA; Bartolucci AA; Dorfman RF Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345 [TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Wollner N; Burchenal JH; Lieberman PH; Exelby P; D'Angio G; Murphy ML Cancer; 1976 Jan; 37(1):123-34. PubMed ID: 1247950 [TBL] [Abstract][Full Text] [Related]
18. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded). Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656 [TBL] [Abstract][Full Text] [Related]